Valina, Christian M.
Merz, Sebastian
Löffelhardt, Nikolaus
Amann, Michael
Ferenc, Miroslaw
Stratz, Christian
Neumann, Franz-Josef
Hochholzer, Willibald
Clinical trials referenced in this document:
Documents that mention this clinical trial
Impact of smoking on antiplatelet effect of clopidogrel and prasugrel after loading dose and on maintenance therapy
https://doi.org/10.1016/j.ahj.2011.06.005
Risk of discontinuation of clopidogrel after 1 month following bare-metal stents: a propensity-score adjusted comparison with continued administration of clopidogrel after drug-eluting stents
https://doi.org/10.1007/s11239-018-1613-6
Article History
First Online: 18 January 2018
Compliance with ethical standards
:
: Dr. Hochholzer reports receiving consulting and lecture fees from AstraZeneca, Boehringer Ingelheim, Daiichi Sankyo, and The Medicines Company. Dr. Stratz reports receiving lecture fees from Eli Lilly. All other authors report no conflict of interests.